Advanced MedAesthetic Partners Fuels Blush Med Spa's Growth with New Location in Orange, CT
ORANGE, Conn., May 14, 2025 /PRNewswire/ -- Advanced MedAesthetic Partners (AMP) is expanding its presence in Connecticut with the launch of Blush Med Spa's newest location in Orange, which opened in May 2025. As a premier destination for cutting-edge aesthetic treatments, Blush Med Spa has built a strong reputation in Avon, Enfield, and Glastonbury. Now, with AMP's support, the brand is extending its reach to serve even more clients seeking advanced, results-driven skincare and aesthetic solutions.
Blush Med Spa has been at the forefront of non-invasive cosmetic treatments for over 15 years, offering a full suite of services, including Botox, Xeomin, dermal fillers, laser treatments, microneedling, and body contouring. Known for blending medical expertise with an artistic approach, Blush empowers clients to enhance their natural beauty through personalized treatment plans.
"This expansion marks an exciting new chapter for Blush," said Camille Karalekas, Blush Med Spa Founder. "We've seen incredible demand for our services, and thanks to AMP's partnership, we're able to bring our signature blend of innovation and patient care to Orange. We look forward to welcoming new clients and continuing to raise the bar in medical aesthetics."
AMP's strategic partnership model is designed to elevate industry-leading practices by providing operational resources, business development expertise, and clinical training—all while preserving each practice's unique identity. By investing in Blush Med Spa's expansion, AMP is not just opening another location—it's reinforcing its commitment to building a strong, sustainable future for medical aesthetics.
"This is more than just a new location—it's a testament to the power of smart growth," said Nicole Chiaramonte, CEO of AMP. "Blush Med Spa's success is a reflection of its dedication to excellence, and we're proud to support its continued expansion. Orange, CT, is the next step in our journey to bring world-class aesthetic care to more communities."
With AMP's rapid expansion and Blush Med Spa's growing influence, this new location creates opportunities not only for clients seeking the latest in aesthetic care but also for top medical professionals looking to join a dynamic, forward-thinking team. As AMP continues to scale, it remains focused on fostering innovation, investing in talent, and setting new industry standards.
For more information about AMP's partnerships and expansion, visit www.weramp.com.
ABOUT AMPAdvanced MedAesthetic Partners (AMP) invests in medical aesthetic practices to drive growth and expansion through strategic partnerships. Our mission is to help practices scale durable businesses while maintaining their unique identity and delivering exceptional care. Leveraging unparalleled expertise, a network of successful entrepreneurs, and a commitment to operational excellence, AMP empowers practices to achieve their long-term vision and thrive in a competitive industry. Learn more at www.weramp.com.
ABOUT LEON CAPITAL GROUPLeon Capital Group (Leon) is a holding company that operates assets in the financial services, healthcare, real estate, and technology industries. Leon is not a private equity fund; it operates as a family holding company overseeing $10 billion of private capital. It takes the lead in conceiving, developing, owning, and operating businesses. Leon started as a modest privately-owned real estate development company in Texas, and has since evolved into a diverse holding company, capable of operating successfully across multiple geographies and industries. Learn more about Leon Capital Group at www.LeonCapitalGroup.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/advanced-medaesthetic-partners-fuels-blush-med-spas-growth-with-new-location-in-orange-ct-302454960.html
SOURCE Advanced Medaesthetic Partners
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
On final day of session, Gov. Abbott vetoes Botox patient safety bill filed after KXAN investigation
AUSTIN (KXAN) — Gov. Greg Abbott vetoed legislation which aimed to enhance Botox patient safety and transparency Monday, calling the measure 'unnecessary and overly-burdensome' for business in Texas. Senate Bill 378 would have prohibited barbers, cosmetologists and estheticians from administering Botox and other injectables unless they were licensed or authorized to give the shots. The measure would also have given the Texas Department of Licensing and Regulation more disciplinary authority over those professionals. 'The passage of SB 378 is a critical step that protects the public from unqualified individuals administering potentially dangerous injections. This common-sense legislation ensures cosmetologists and barbers are not performing injections without proper physician supervision,' the bill's author, Sen. Charles Schwertner, R-Georgetown, explained after the measure was sent to the governor on May 21. KXAN has reached out to Schwertner's office for comment after the veto. 'Texas should be removing barriers for small businesses and occupational licensees,' Senate Secretary Patsy Spaw said on the chamber floor Monday, reading the governor's written words verbatim. 'Senate Bill 378 by Schwertner does just the opposite by, among other things, prohibiting a licensed cosmetologist or barber from 'making an incision into the dermis, layer of a person's skin.' Barbers who nick a customer's neck during a straight razor shave should not fear the loss of their licenses as we work to make government more efficient and less intrusive for Texans and businesses.' While most of the governor's vetoes will be delivered after the session, SB 378's passage timeline required him to take action sooner or the bill would have gone into law without his signature. It is his first veto of a Senate bill this session. 'I disapprove of this bill,' Abbott wrote to Senators before sine die, the official end of the session. 'Since you remain gathered in regular session and continue to conduct formal business, I am delivering this disapproval message directly to you along with the unsigned official enrolled copy of the bill.' Schwertner told lawmakers earlier in the session there have been increased reports of 'Botox parties' which include unauthorized and unsafe injections to friends and family without proper supervision. RELATED: 'Botox party' bill heads to governor Schwertner previously shared with KXAN investigators that, by law, estheticians and cosmetologists can only perform injections, including Botox, under the authority of a physician. He added that while the Texas Medical Board has disciplinary authority over physicians who are authorizing the injections, there is no oversight when it comes to professionals including estheticians or cosmetologists who could be in violation. During a House committee hearing in April, lawmakers received nearly 50 written comments from many Texas estheticians and injectors opposing the legislation and sharing concerns about their businesses being impacted. KXAN INVESTIGATION: Backroom Botox a 'wild west' in Texas Patient protection advocates have been pushing for oversight in the growing industry. The legislation was filed after a KXAN investigation uncovered that anyone in Texas can become certified to do injections, including Botox. KXAN's 'Backroom Botox' investigation highlighted medical concerns after a Botox treatment led to an emergency in the back room of a local boutique in Dublin, a city north of Austin. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
11 hours ago
- Yahoo
Dr. Alexander Rivkin Co-Authors Landmark Phase 2B Study on OnabotulinumtoxinA for Masseter Muscle Prominence Published in Aesthetic Surgery Journal
Internationally renowned aesthetic expert Dr. Alexander Rivkin contributes to groundbreaking research demonstrating the safety and efficacy of Botox® treatment for masseter muscle prominence reduction. The comprehensive study, published in the prestigious Aesthetic Surgery Journal, represents a significant advancement in non-surgical facial contouring treatments. LOS ANGELES, June 2, 2025 /PRNewswire/ -- Dr. Alexander Rivkin, globally recognized pioneer in non-surgical rhinoplasty and facial aesthetic procedures, has co-authored a pivotal Phase 2B clinical study demonstrating the safety and efficacy of onabotulinumtoxinA (Botox®) for treating masseter muscle prominence. The comprehensive research, titled "A Controlled Phase 2b Trial to Assess the Efficacy and Safety of a Single Intervention of OnabotulinumtoxinA for Treating Masseter Muscle Prominence," has been published in the prestigious Aesthetic Surgery Journal and is accessible at Dr. Rivkin collaborated with leading international researchers including Dr. Steven Liew, Dr. Derek Jones, Dr. Steven Dayan, Dr. Sabrina Fabi, and Dr. Brian Biesman on this landmark multicenter, randomized, double-blind, placebo-controlled trial. The study evaluated the effectiveness of onabotulinumtoxinA in reducing masseter muscle prominence—a condition that can create a wide, square jawline appearance and affect facial aesthetics. The research findings demonstrated that onabotulinumtoxinA administered in single or multiple treatments over one year was associated with significant reductions in masseter muscle volume and prominence severity, while maintaining an acceptable safety profile. The study represents a major advancement in understanding how botulinum toxin can be safely and effectively used for lower facial contouring. "This research represents an important milestone in expanding our treatment options for patients seeking non-surgical facial enhancement," said Dr. Rivkin. "The results provide valuable clinical evidence supporting the use of onabotulinumtoxinA for masseter muscle prominence, allowing us to offer patients a safe, effective solution for achieving more refined facial contours without surgery." The comprehensive study involved multiple international clinical sites and represents years of meticulous research and data collection. For patients with masseter muscle prominence—often characterized by a square or wide lower face appearance—this treatment offers a minimally invasive alternative to surgical interventions. The research findings support the growing trend toward non-surgical facial contouring procedures that can achieve significant aesthetic improvements with minimal downtime. Dr. Rivkin's participation in this landmark study underscores his commitment to advancing the field of aesthetic medicine through rigorous clinical research. As a leader in non-surgical facial treatments and pioneer of the non-surgical rhinoplasty technique, Dr. Rivkin continues to contribute to the scientific literature that guides best practices in aesthetic medicine. More About Dr. Alexander RivkinDr. Alexander Rivkin is a facial aesthetic specialist and Assistant Clinical Professor at the David Geffen School of Medicine at UCLA. He received his undergraduate degree from Columbia University and his medical degree from Yale University School of Medicine, his residency in Otolaryngology/Head and Neck Surgery was at the University of California, San Diego. Dr. Rivkin is globally recognized as a pioneer in non-surgical rhinoplasty and has authored numerous peer-reviewed publications on aesthetic procedures. Dr. Rivkin's practice, RIVKIN Aesthetics, is located in Beverly Hills and Los Angeles, offering cutting-edge non-surgical facial treatments and aesthetic procedures. The practice is renowned for natural-looking results and innovative treatment approaches that prioritize patient safety and satisfaction. For more information about Dr. Alexander Rivkin or to schedule a consultation, please visit Media ContactDr. Alexander RivkinRIVKIN Aesthetics(310) View original content to download multimedia: SOURCE RIVKIN Aesthetics
Yahoo
12 hours ago
- Yahoo
These 5 KXAN investigations sparked bills landing on the Texas governor's desk
AUSTIN (KXAN) – This session, Texas lawmakers filed around 50 bills sparked by or following KXAN investigations on a wide range of important topics from schools and health care to criminal justice and constitutional law. Many of those advanced far in the legislative process, while a handful even made it the governor's desk and will likely become law. Two bills related to the state's 'Do Not Hire' registries made it to the governor. He already signed Senate Bill 1437 into law, allowing the Texas Juvenile Justice Department to designate former employees or volunteers permanently ineligible for certification if they engage in conduct that threatens juvenile safety. The other expected to be signed is Senate Bill 571, which expands the Texas Education Agency's authority to investigate volunteers and third-part contractors who work on school campuses and are accused of misconduct. These bills were filed after KXAN revealed a juvenile corrections officer was able to get a tutoring job at an Austin ISD campus while under investigation for sexual misconduct by a state agency. Part of Senate Bill 1, the budget bill sent to the governor, includes a change to the state's crime victim compensation fund, which pays victims and their loved ones for recovery costs and other items like funeral expenses. It requires the Texas attorney general's office, which manages the fund, to give a more accurate picture of how quickly victims are paid and how well the program is working. It comes after KXAN discovered a flawed data formula was showing a much shorter wait time than the actual eight-month average to receive a first payment. The new law aims to have that happen in under 90 days. Another bill signed by the governor that will impact the attorney general's office is Senate Bill 1403, dealing with the agency's child support division. It allows the attorney general to speed up procedures to cut down on unnecessary delays in delivering child support payments. The agency will also now be able to get information directly to families at courthouses and on its website. The measure comes after a KXAN investigation highlighted concerns from parents owed billions of dollars in child support. A measure pushing Botox patient safety and transparency will also become law. Senate Bill 378 prohibits barbers, cosmetologists and estheticians from administering Botox and other injectables unless they are licensed or authorized to give the shots. It also gives the Texas Department of Licensing and Regulation more disciplinary authority over those professionals. Several Texas estheticians and injectors registered their opposition to the bill this session. KXAN's reporting revealed anyone in Texas can become certified to do injections, including Botox, and highlighted the lack of oversight concerning medical experts. Another measure, Senate Bill 660, related to patient safety and sparked by a KXAN investigation didn't make it over the legislative finish line. The hospital security measure cleared the Senate but stalled in a House committee. In its original form, it would have required hospitals to have security barriers at their entrances statewide. The bill was filed after KXAN's coverage of a deadly crash into an Austin emergency room last year, which led to a local ordinance requiring those devices at all new hospitals in the city. The state legislation, however, met heavy resistance from the Texas Hospital Association, largely over costs, even as lawmakers used KXAN's data to illustrate the frequency of these kinds of crashes into medical centers. The dataset now lists more than 580 over the last decade nationwide – many of those in Texas. The bill's author, Sen. Royce West, D-Dallas, said he plans to re-file next session. Another medical-related bill filed after KXAN's reporting would have expanded the use of medical examiners for death investigations in more counties across Texas. It came after we revealed most counties don't have medical examiners – doctors trained for that purpose – and instead rely on elected justices of the peace who often lack expertise in this area. Senate Bill 1370 died along with many other bills at a midnight House deadline in the session's final week, just one step from the governor's desk. But its sponsor, Rep. Rafael Anchia, D-Dallas, tells KXAN he plans to call for an interim charge to study how to attract more doctors with this expertise to fill the growing need in Texas ahead of the next session. Also, looking ahead to next session, the author of House Bill 1738, Rep. Venton Jones, D-Dallas, said he plans to re-file his legislation aimed at repealing the state's unconstitutional ban on 'homosexual conduct.' KXAN's analysis shows, since the 1980s, there have been at least 60 attempts to do just that – most of those since the U.S. Supreme Court's 2003 ruling struck down the law as unenforceable. HB 1978, which was filed after a KXAN investigation, made it further in the legislative process than any of those past bills. Critics say leaving the old law on the books allows for police and policymakers' misinterpretation of it. The governor has until June 22 to sign, veto or allow bills to become law without his signature. Several this session – including others on open government and state hospital beds – started with KXAN viewer tips. If you have something you think we should investigate, reach out to our investigative team. The following KXAN journalists contributed to this report: Digital Data Reporter Christopher Adams, Senior Investigative Producer David Barer, Investigative Photojournalist Richie Bowes, Investigative Reporter Arezow Doost, Investigative Reporter Matt Grant, Investigative Producer Dalton Huey, Investigative Photojournalist Chris Nelson, Digital Special Projects Developer Robert Sims, Investigative Reporter Kelly Wiley, Digital Director Kate Winkle Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
